More about
Teprotumumab
News
October 23, 2020
2 min read
Save
Teprotumumab confers long-term benefits in thyroid eye disease
News
July 31, 2020
3 min read
Save
Top-line data demonstrate efficacy, safety of teprotumumab for thyroid eye disease
News
April 02, 2020
3 min read
Save
Smokers, women experience proptosis reduction with teprotumumab in thyroid eye disease

High-risk adults with active thyroid eye disease, such as smokers, women and older adults, experienced a reduction in outward bulging of the eye at 24 weeks that was similar to adults at lower risk for the disease, according to findings accepted for presentation at the Endocrine Society Annual Meeting.